Pharmaceutical group ยท United States
Viatris
A group of 142 companies with 3,312 medicines in 12 countries.
Group structure
142 companies in 24 countries
Loadingโฆ
Pharmaceutical group ยท United States
A group of 142 companies with 3,312 medicines in 12 countries.
142 companies in 24 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 3,312
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABACAVIR/LAMIVUDINA VIATRIS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG702,78 mg + 300 mg ยท Comprimido recubierto con pelรญcula | Abacavir, Lamivudine | Spain | Marketed | 2018 |
| Abacavir/Lamivudine Viatris 600 mg/300 mg, filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine | Netherlands | Authorised | 2017 |
| Abacavir/Lamivudine/Zidovudine Mylan 300 mg/150 mg/300 mg filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine, Zidovudine | Netherlands | Authorised | 2014 |
| ABACAVIR SULFATE300mg | 300mg base | 60 mg | 60mg ยท Tablet | Abacavir | United States | Marketed | 2007 |
| Abirateron Mylan 1000 mg, filmomhulde tabletFilmomhulde tablet | Abiraterone | Netherlands | Authorised | 2021 |
| Abirateron Mylan 500 mg, filmomhulde tabletFilmomhulde tablet | Abiraterone | Netherlands | Authorised | 2021 |
| ABIRATERONA MYLAN 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA1000 mg ยท Comprimido recubierto con pelรญcula | Abiraterone | Spain | Marketed | 2022 |
| ABIRATERONA MYLAN 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg ยท Comprimido recubierto con pelรญcula | Abiraterone | Spain | Authorised | 2022 |
| Abiraterone Mylan | Abiraterone | EU (EMA) | Authorised | 2021 |
| ACARBOSA VIATRIS 100 MG COMPRIMIDOS100,00 mg ยท Comprimido | Acarbose | Spain | Marketed | 2009 |
| ACARBOSA VIATRIS 50 MG COMPRIMIDOS50,00 mg ยท Comprimido | Acarbose | Spain | Marketed | 2009 |
| ACETILCISTEINA VIATRIS 200 mg GRANULADO PARA SOLUCION ORAL EFG200 mg ยท Granulado para soluciรณn oral | Acetylcysteine | Spain | Marketed | 2002 |
| ACETILCISTEINA VIATRIS 600 MG GRANULADO EFERVESCENTEL EFG600 mg ยท Granulado efervescente | Acetylcysteine | Spain | Marketed | 2002 |
| Acetylsalicylzuur Cardio Mylan 80 mg, dispergeerbare tablettenDispergeerbare tablet | Acetylsalicylzuur | Netherlands | Authorised | 2002 |
| ACICLOVIR VIATRIS 50MG/G CREMA EFG5,00 g ยท Crema | Aciclovir | Spain | Marketed | 2003 |
| ACIDO ACETILSALICILICO VIATRIS 100 MG COMPRIMIDOS GASTRORRESISTENTES100 mg ยท Comprimido gastrorresistente | Acetylsalicylic acid | Spain | Marketed | 2021 |
| ACIDO ALENDRONICO SEMANAL VIATRIS 70 mg COMPRIMIDOS EFG70 mg ยท Comprimido | Alendronic acid | Spain | Marketed | 2005 |
| ACIDO IBANDRONICO VIATRIS 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG150 mg ยท Comprimido recubierto con pelรญcula | Ibandronic acid | Spain | Marketed | 2011 |
| ACIDO TRANEXAMICO VIATRIS 100 MG/ML SOLUCION INYECTABLE EFG500 mg ยท Soluciรณn inyectable | Tranexamic acid | Spain | Marketed | 2026 |
| รกcido zoledrรดnico | Zoledronic acid | Brazil | Authorised | 2018 |
| Acopair 18 mikrograma, praลกak inhalata, tvrde kapsule*praลกak inhalata, tvrda kapsula | Tiotropium bromide | Croatia | Not marketed | 2024 |
| Aforbe 100/6 mikrograma po potisku, stlaฤeni inhalat, otopinaStlaฤeni inhalat, otopina | Beclometasone, Formoterolfumarat | Croatia | Marketed | 2022 |
| AGIOLAX | Plantago ovata forssk., Senna alexandrina mill. | Brazil | Authorised | 2018 |
| Aldara | Imiquimod | EU (EMA) | Authorised | 1998 |
| Aldaraย50mg/g ยท krem | Imiquimod | Serbia | Authorised | 2022 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 873 | 735 | 138 | CompaniesAll medicines |
| Netherlands | 872 | 872 | 0 | CompaniesAll medicines |
| Canada | 652 | 137 | 515 | CompaniesAll medicines |
| Serbia | 190 | 190 | 0 | CompaniesAll medicines |
| Croatia | 183 | 183 | 0 | CompaniesAll medicines |
| United States | 168 | 149 | 19 | CompaniesAll medicines |
| Brazil | 119 | 60 | 59 | CompaniesAll medicines |
| Romania | 84 | 0 | 84 | CompaniesAll medicines |
| European Union (EMA) | 78 | 58 | 20 | CompaniesAll medicines |
| Singapore | 73 | 73 | 0 | CompaniesAll medicines |
| Saudi Arabia | 14 | 14 | 0 | CompaniesAll medicines |
| Italy | 6 | 6 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Colombia, France, Germany, Malaysia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agรชncia Nacional de Vigilรขncia Sanitรกria (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Federal Commercial Registry Office;exact dataset/law title,source URI/link and retrieval date;Prognia separately labelled normalization;no endorsement.
Licence: opendata.swiss terms_by
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Bundesinstitut fรผr Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.
Licence: commercial redistribution permission not established
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche dโentreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA factual register
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods JanuaryโSeptember 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brรธnnรธysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence: Norwegian Licence for Open Government Data
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licence: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Keep Viatrisโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.